Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy
Glutathione is taking three amino acids together, two enzymes, two molecules of ATP, which is energy, and one molecule of NAD for electron transfer
Cardiovascular disease, secondary prevention: Oral maintenance doses of L-carnitine 2 to 6 g/day for up to 12 months have been used in clinical studies
The 250g bag already delivers substantially better value than the 100g option, while the 500g and 1kg sizes are among the least expensive ways to maintain a long-term NAC regimen
This recent review describes the range of hepatic manifestations observed in patients with WD
Data sheet 16 other products in the same category: Customers who bought this product also bought: